SEC Form 4 · accession 0001683168-17-002253
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Stephens
Officer — Acting Chief Financial Officer
Period of report
Aug 25, 2017
Accepted (ET)
Aug 30, 2017 · 2:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.25 | Aug 25, 2017 | A | 70,000 | A | — | Aug 25, 2027 | Common Stock | 70,000 | 150,000 | D |
Explanation of responses
- F1Upon becoming an officer of the company, the reporting person was awarded stock options. The option vest is 3/36th on initial vesting date (08/25/2017) and 1/36th for each additional full month of continuous service from the initial vesting date.